Dexmedetomidine and hydromorphone: A novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children
Keyword(s):
2004 ◽
Vol 9
(2)
◽
pp. 120-128
◽
2020 ◽
Vol 25
(Sup12)
◽
pp. S20-S24
Keyword(s):
2004 ◽
Vol 44
(2)
◽
pp. 121-127
◽
Keyword(s):
2003 ◽
Vol 40
(5)
◽
pp. ix
◽
2021 ◽
Vol 2
(3)
◽
Keyword(s):